NASDAQ 100
29.183,65
PKT
-51,34
PKT
-0,18
%
Indikation, realtime*
29.234,99
PKT
+671,05
PKT
+2,35
%
Offiziell
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.01.12 | Apple buy | Jefferies & Company Inc. | |
| 19.01.12 | Tesla buy | Goldman Sachs Group Inc. | |
| 19.01.12 | Amazon outperform | RBC Capital Markets | |
| 19.01.12 | Apple outperform | RBC Capital Markets | |
| 19.01.12 | Amgen outperform | RBC Capital Markets | |
| 19.01.12 | Apple overweight | Barclays Capital | |
| 19.01.12 | Apple outperform | Robert W. Baird & Co. Incorporated | |
| 19.01.12 | Alphabet A (ex Google) buy | Needham & Company, LLC | |
| 18.01.12 | Kraft Heinz Company buy | Stifel, Nicolaus & Co., Inc. | |
| 18.01.12 | Intel neutral | JP Morgan Chase & Co. | |
| 18.01.12 | Kraft Heinz Company buy | UBS AG | |
| 18.01.12 | eBay neutral | Nomura | |
| 18.01.12 | Apple overweight | Piper Jaffray & Co. | |
| 18.01.12 | Microsoft outperform | RBC Capital Markets | |
| 18.01.12 | Tesla overweight | Barclays Capital | |
| 18.01.12 | Tesla outperform | Robert W. Baird & Co. Incorporated | |
| 18.01.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 18.01.12 | lululemon athletica outperform | RBC Capital Markets | |
| 18.01.12 | Starbucks outperform | Williams Capital | |
| 18.01.12 | Alphabet A (ex Google) buy | Jefferies & Company Inc. | |
| 17.01.12 | Applied Materials outperform | RBC Capital Markets | |
| 17.01.12 | Honeywell neutral | UBS AG | |
| 17.01.12 | Linde neutral | J.P. Morgan Cazenove | |
| 16.01.12 | Booking overweight | JP Morgan Chase & Co. | |
| 16.01.12 | Amazon overweight | JP Morgan Chase & Co. | |
| 13.01.12 | Xcel Energy neutral | Robert W. Baird & Co. Incorporated | |
| 13.01.12 | Apple overweight | Piper Jaffray & Co. | |
| 13.01.12 | Microsoft outperform | Sanford C. Bernstein and Co., Inc. | |
| 13.01.12 | Tesla overweight | Barclays Capital | |
| 13.01.12 | Biogen overweight | Barclays Capital | |
| 13.01.12 | Booking overweight | Piper Jaffray & Co. | |
| 12.01.12 | Linde neutral | Robert W. Baird & Co. Incorporated | |
| 12.01.12 | Intel outperform | Credit Suisse Group | |
| 12.01.12 | Linde buy | Citigroup Corp. | |
| 12.01.12 | Microsoft buy | UBS AG | |
| 12.01.12 | Apple buy | UBS AG | |
| 12.01.12 | Intel reduce | Nomura | |
| 12.01.12 | Starbucks kaufen | Aktienservice Research | |
| 11.01.12 | Linde buy | Commerzbank Corp. & Markets | |
| 11.01.12 | Microsoft buy | Nomura |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.